To provide novel functionalized lactams as modulators of the 5-hydroxytryptamine
receptor 7 and methods of using the same.SOLUTION: Described herein are new, selective modulators of the 5-HT7
receptor. These selective compounds may be useful for the treatment of CNS and non-CNS indications. The compounds described herein may be selective in targeting 5-HT7 receptors as compared to other receptors and / or by selectively targeting 5-HT7 receptors expressed in certain tissues or organs, thereby providing effective selectivity through a particular partitioning profile of the 5-HT7 modulator.SELECTED DRAWING: None